Hyaluronic Acid Dermal Filler Market Is Poised To Reach $6.04 Billion By 2025

San Francisco, 23 Oct 2019 - The global hyaluronic acid dermal filler market size is expected to reach USD 6.04 billion by 2025, as per a new report by Grand View Research, Inc. The market is expected to register a CAGR of 8.31% over the forecast period. This growth can be attributed to rising importance of quality of life and overall health. Moreover, technological innovations in the industry are likely to boost the market further. According to the International Society of Plastic Surgery (ISAPS), in 2016 hyaluronic acid based dermal filler procedures were the second-most preferred injectable across the globe.

These fillers are commonly used for aesthetic procedures, such as improving nasolabial folds, reducing eye wrinkles, dark circles, and scars. Hyaluronic acid injections are easy to use, effective, and relatively less expensive. These associated advantages are expected to drive the market growth during the forecast period. Increasing awareness and popularity of aesthetic procedures along with the presence of FDA-approved hyaluronic acid-based synthetic products, such as Restylane, Juvederm, Perlane, and Hylaform Plus, are also likely to drive the market in the coming years.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/hyaluronic-acid-based-dermal-fillers-market

Further key findings from the study suggest:

• Single-phase products led the hyaluronic acid based dermal filler market due to their preference for procedures, such as deep and medium wrinkle removal
• Wrinkle removal procedure was one of the leading segments in 2017. Increasing influence of social media advertisements promoting flawless younger-looking skin is expected to drive the segment further
• Geographically, North America held the largest market share in 2017 on account of higher number of minimally invasive cosmetic surgeries performed in the region
• Asia Pacific is expected to witness the highest CAGR due to growing awareness about applications of minimally invasive techniques in emerging economies, such as China, and increasing disposable income levels
• Some of the key companies in the market are ALLERGAN PLC; Galderma S.A.; Merz Pharma GmbH & Co. KGaA; Genzyme Corporation, Medicis Aesthetics Holdings, Inc.; and Anika Therapeutics, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For More Information: www.grandviewresearch.com